Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 2090286, 10 pages
http://dx.doi.org/10.1155/2016/2090286
Research Article

Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma

1School of Computer Science and Technology, Xidian University, Xi’an 710000, China
2Department of Biomedical Engineering, School of Control Science and Engineering, Shandong University, Shandong 250061, China
3Key Laboratory of Systems Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
4Institute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan
5School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China

Received 28 May 2016; Revised 28 June 2016; Accepted 5 July 2016

Academic Editor: Quan Zou

Copyright © 2016 Xindong Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zhang and B. Cai, “The impact of tobacco on lung health in China,” Respirology, vol. 8, no. 1, pp. 17–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle, “Estimates of the cancer incidence and mortality in Europe in 2006,” Annals of Oncology, vol. 18, no. 3, pp. 581–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-K. Toh, F. Gao, W.-T. Lim et al., “Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity,” Journal of Clinical Oncology, vol. 24, no. 15, pp. 2245–2251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Hu and G. Chen, “Pathogenic mechanisms of lung adenocarcinoma in smokers and non-smokers determined by gene expression interrogation,” Oncology Letters, vol. 10, no. 3, pp. 1350–1370, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. D. De Carvalho, S. Sharma, J. S. You et al., “DNA methylation screening identifies driver epigenetic events of cancer cell survival,” Cancer Cell, vol. 21, no. 5, pp. 655–667, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Delpu, P. Cordelier, W. C. Cho, and J. Torrisani, “DNA methylation and cancer diagnosis,” International Journal of Molecular Sciences, vol. 14, no. 7, pp. 15029–15058, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. D. De Carvalho, J. S. You, and P. A. Jones, “DNA methylation and cellular reprogramming,” Trends in Cell Biology, vol. 20, no. 10, pp. 609–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Meissner, “Epigenetic modifications in pluripotent and differentiated cells,” Nature Biotechnology, vol. 28, no. 10, pp. 1079–1088, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Momparler and V. Bovenzi, “DNA methylation and cancer,” Journal of Cellular Physiology, vol. 183, no. 2, pp. 145–154, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kulis and M. Esteller, “DNA methylation and cancer,” in Advances in Genetics, H. Zdenko and U. Toshikazu, Eds., pp. 27–56, Academic Press, 2010. View at Google Scholar
  11. N. The Cancer Genome Atlas Research, “Comprehensive genomic characterization of squamous cell lung cancers,” Nature, vol. 489, no. 7417, pp. 519–525, 2012. View at Publisher · View at Google Scholar
  12. I. Balgkouranidou, T. Liloglou, and E. S. Lianidou, “Lung cancer epigenetics: emerging biomarkers,” Biomarkers in Medicine, vol. 7, no. 1, pp. 49–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Kalari and G. P. Pfeifer, “Identification of driver and passenger DNA methylation in cancer by epigenomic analysis,” Advances in Genetics, vol. 70, pp. 277–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Jjingo, A. B. Conley, S. V. Yi, V. V. Lunyak, and I. King Jordan, “On the presence and role of human gene-body DNA methylation,” Oncotarget, vol. 3, no. 4, pp. 462–474, 2012. View at Google Scholar · View at Scopus
  15. X. Yang, H. Han, D. D. DeCarvalho, F. D. Lay, P. A. Jones, and G. Liang, “Gene body methylation can alter gene expression and is a therapeutic target in cancer,” Cancer Cell, vol. 26, no. 4, pp. 577–590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Teodoridis, G. Strathdee, and R. Brown, “Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker,” Drug Resistance Updates, vol. 7, no. 4-5, pp. 267–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Sigalotti, E. Fratta, S. Coral et al., “Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications,” Journal of Cellular Physiology, vol. 212, no. 2, pp. 330–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. A. Selamat, B. S. Chung, L. Girard et al., “Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression,” Genome Research, vol. 22, no. 7, pp. 1197–1211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Tessema, C. M. Yingling, Y. Liu et al., “Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers,” Carcinogenesis, vol. 35, no. 6, pp. 1248–1257, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Karlsson, M. Jönsson, M. Lauss et al., “Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome,” Clinical Cancer Research, vol. 20, no. 23, pp. 6127–6140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Sato, E. Arai, T. Kohno et al., “Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: its correlation with smoking history and chronic obstructive pulmonary disease,” International Journal of Cancer, vol. 135, no. 2, pp. 319–334, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Zeng, X. Zhang, and Q. Zou, “Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks,” Briefings in Bioinformatics, vol. 17, no. 2, pp. 193–203, 2016. View at Publisher · View at Google Scholar
  23. Q. Zou, J. Li, L. Song, X. Zeng, and G. Wang, “Similarity computation strategies in the microRNA-disease network: a survey,” Briefings in Functional Genomics, vol. 15, no. 1, pp. 55–64, 2016. View at Publisher · View at Google Scholar
  24. W. Huber, A. Von Heydebreck, H. Sültmann, A. Poustka, and M. Vingron, “Variance stabilization applied to microarray data calibration and to the quantification of differential expression,” Bioinformatics, vol. 18, no. 1, pp. S96–S104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. D. Storey, “A direct approach to false discovery rates,” Journal of the Royal Statistical Society, Series B: Statistical Methodology, vol. 64, no. 3, pp. 479–498, 2002. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  26. E. Lee, H.-Y. Chuang, J.-W. Kim, T. Ideker, and D. Lee, “Inferring pathway activity toward precise disease classification,” PLoS Computational Biology, vol. 4, no. 11, Article ID e1000217, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. J. Faith, B. Hayete, J. T. Thaden et al., “Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles,” PLoS Biology, vol. 5, no. 1, article e8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. C. O. Daub, R. Steuer, J. Selbig, and S. Kloska, “Estimating mutual information using B-spline functions—an improved similarity measure for analysing gene expression data,” BMC Bioinformatics, vol. 5, no. 1, article 118, pp. 1–12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Olsen, P. E. Meyer, and G. Bontempi, “On the impact of entropy estimation on transcriptional regulatory network inference based on mutual information,” Eurasip Journal on Bioinformatics and Systems Biology, vol. 2009, Article ID 308959, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Ideker and N. J. Krogan, “Differential network biology,” Molecular Systems Biology, vol. 8, article 565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A.-L. Barabási and Z. N. Oltvai, “Network biology: understanding the cell's functional organization,” Nature Reviews Genetics, vol. 5, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Pastuszak-Lewandoska, K. H. Czarnecka, M. Migdalska-Sęk et al., “Decreased FAM107A expression in patients with non-small cell lung cancer,” Advances in Experimental Medicine and Biology, vol. 852, pp. 39–48, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Xiang, Q. Qiu, M. Jiang et al., “SPARCL1 suppresses metastasis in prostate cancer,” Molecular Oncology, vol. 7, no. 6, pp. 1019–1030, 2013. View at Google Scholar
  36. P. Li, J. Qian, G. Yu et al., “Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer,” Journal of Surgical Oncology, vol. 105, no. 1, pp. 31–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. F. Pla and D. Gkika, “Emerging role of TRP channels in cell migration: from tumor vascularization to metastasis,” Frontiers in Physiology, vol. 4, article 311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Qin, Y. Ni, J. Tong et al., “Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer,” Medical Oncology, vol. 31, no. 8, article 142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Wang, Q. Chen, Z. Chen et al., “EFEMP2 is upregulated in gliomas and promotes glioma cell proliferation and invasion,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 9, pp. 10385–10393, 2015. View at Google Scholar
  40. M. Watanabe, N. Komeshima, S. Nakajima, and T. Tsuruo, “MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells,” Cancer Research, vol. 48, no. 23, pp. 6653–6657, 1988. View at Google Scholar · View at Scopus
  41. K. Kobayashi, M. Nishioka, T. Kohno et al., “Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo,” Oncogene, vol. 23, no. 17, pp. 3089–3096, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Hartmann, L. Johnk, H. Sasaki, R. B. Jenkins, and D. N. Louis, “Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas,” Brain Pathology, vol. 12, no. 2, pp. 178–182, 2002. View at Google Scholar · View at Scopus
  43. P. D. Bos, X. H.-F. Zhang, C. Nadal et al., “Genes that mediate breast cancer metastasis to the brain,” Nature, vol. 459, no. 7249, pp. 1005–1009, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Buccheri and D. Ferrigno, “Lung tumour markers in oncology practice: a study of TPA and CA125,” British Journal of Cancer, vol. 87, no. 10, pp. 1112–1118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. L. T. Smith, M. Lin, R. M. Brena et al., “Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 4, pp. 982–987, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Yin, Y. Jia, Y. Yu et al., “SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer,” Discovery Medicine, vol. 14, no. 74, pp. 33–40, 2012. View at Google Scholar · View at Scopus
  47. S. Dasgupta, J. S. Jang, C. Shao et al., “SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling,” Journal of Molecular Medicine (Berlin, Germany), vol. 91, no. 3, pp. 381–393, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. N. E. Reticker-Flynn and S. N. Bhatia, “Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche,” Cancer Discovery, vol. 5, no. 2, pp. 168–181, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Chen, C. Sullivan, C. Peng et al., “A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia,” Blood, vol. 118, no. 2, pp. 390–400, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Lokk, T. Vooder, R. Kolde et al., “Methylation markers of early-stage non-small cell lung cancer,” PLoS ONE, vol. 7, no. 6, article e39813, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Fischer, R. Stenling, C. Rubio, and A. Lindblom, “Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2,” Carcinogenesis, vol. 22, no. 6, pp. 875–878, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Sato, K. Soejima, E. R. I. Arai et al., “Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer,” Oncology Reports, vol. 34, no. 3, pp. 1137–1145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. G.-H. Li and J.-F. Huang, “Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer,” Bioinformatics, vol. 30, no. 6, pp. 748–752, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. K. O. Toyooka, S. Toyooka, A. K. Virmani et al., “Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas,” Cancer Research, vol. 61, no. 11, pp. 4556–4560, 2001. View at Google Scholar · View at Scopus
  55. M. Okroj, Y.-F. Hsu, D. Ajona, R. Pio, and A. M. Blom, “Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors,” Molecular Immunology, vol. 45, no. 1, pp. 169–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Schveigert, S. Cicenas, S. Bruzas, N. Samalavicius, Z. Gudleviciene, and J. Didziapetriene, “The value of MMP-9 for breast and non-small cell lung cancer patients' survival,” Advances in Medical Sciences, vol. 58, no. 1, pp. 73–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Wrangle, E. O. Machida, L. Danilova et al., “Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer,” Clinical Cancer Research, vol. 20, no. 7, pp. 1856–1864, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Alavi, V. Mah, E. L. Maresh et al., “High expression of AGR2 in lung cancer is predictive of poor survival,” BMC Cancer, vol. 15, no. 1, article 655, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Bartling, G. Rehbein, W. D. Schmitt, H.-S. Hofmann, R.-E. Silber, and A. Simm, “S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy,” European Journal of Cancer, vol. 43, no. 13, pp. 1935–1943, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Rehbein, A. Simm, H.-S. Hofmann, R.-E. Silbar, and B. Bartling, “Molecular regulation of S100P in human lung adenocarcinomas,” International Journal of Molecular Medicine, vol. 22, no. 1, pp. 69–77, 2008. View at Google Scholar · View at Scopus
  61. H. Nishihara, M. Maeda, A. Oda et al., “DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines,” Blood, vol. 100, no. 12, pp. 3968–3974, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. X. Guan, Z. Liao, H. Ma et al., “TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy,” BMC Cancer, vol. 11, article 447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Kanehisa, Y. Sato, M. Kawashima, M. Furumichi, and M. Tanabe, “KEGG as a reference resource for gene and protein annotation,” Nucleic Acids Research, vol. 44, no. 1, pp. D457–D462, 2016. View at Publisher · View at Google Scholar
  64. A. Subramanian, P. Tamayo, V. K. Mootha et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15545–15550, 2005. View at Publisher · View at Google Scholar · View at Scopus